Venture Certified
| 기술평가보증기업(기금) | 2006-10-18 ~ 2007-10-17 | 20060100273 | 2006-10-18 |
| 기술평가보증기업(기금) | 2007-10-18 ~ 2008-10-17 | 20070104268 | 2006-10-18 |
| 연구개발유형 | 2008-10-18 ~ 2010-10-17 | 20080108385 | 2006-10-18 |
| 연구개발유형 | 2013-06-21 ~ 2015-06-20 | 20130400537 | 2006-10-18 |
| 연구개발유형 | 2016-01-18 ~ 2018-01-17 | 20160100315 | 2006-10-18 |
| 벤처투자유형 | 2018-01-18 ~ 2020-01-17 | 20180300015 | 2006-10-18 |
| 벤처투자유형 | 2020-01-18 ~ 2022-01-17 | 20200300092 | 2006-10-18 |
| 연구개발유형 | 2023-05-17 ~ 2026-05-16 | 20230517020025 | 2006-10-18 |
Revenue CAGR +60.9%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 37.4B | 20.9B | 14.5B |
| Operating Profit | -4.6B | -6.2B | -10.8B |
| Net Profit | -4.6B | -11.1B | -10.0B |
| Total Assets | 147.7B | 131.9B | 131.0B |
| Total Liabilities | 52.2B | 53.0B | 52.2B |
| Total Equity | 95.5B | 78.8B | 78.8B |
Operating Loss: Op. profit -5B
3 Consecutive Years of Net Loss
▲ 111.6%
▲ 45.7%
▲ 76.4%
▼ 18.2%
▲ 63.9%
| Name | Position | Role |
|---|---|---|
| 이석호 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 시흥시",
"ceo_name": "이석호",
"certificate": [
{
"cert_number": "20060100273",
"changes": "",
"disclosure_date": "2006-10-18",
"first_cert_date": "2006-10-18",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2006-10-18 ~ 2007-10-17"
},
{
"cert_number": "20070104268",
"changes": "",
"disclosure_date": "2007-11-27",
"first_cert_date": "2006-10-18",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2007-10-18 ~ 2008-10-17"
},
{
"cert_number": "20080108385",
"changes": "",
"disclosure_date": "2008-12-11",
"first_cert_date": "2006-10-18",
"no": "3",
"type": "연구개발유형",
"valid_period": "2008-10-18 ~ 2010-10-17"
},
{
"cert_number": "20130400537",
"changes": "",
"disclosure_date": "2013-06-21",
"first_cert_date": "2006-10-18",
"no": "4",
"type": "연구개발유형",
"valid_period": "2013-06-21 ~ 2015-06-20"
},
{
"cert_number": "20160100315",
"changes": "",
"disclosure_date": "2016-01-18",
"first_cert_date": "2006-10-18",
"no": "5",
"type": "연구개발유형",
"valid_period": "2016-01-18 ~ 2018-01-17"
},
{
"cert_number": "20180300015",
"changes": "",
"disclosure_date": "2018-01-11",
"first_cert_date": "2006-10-18",
"no": "6",
"type": "벤처투자유형",
"valid_period": "2018-01-18 ~ 2020-01-17"
},
{
"cert_number": "20200300092",
"changes": "",
"disclosure_date": "2020-01-30",
"first_cert_date": "2006-10-18",
"no": "7",
"type": "벤처투자유형",
"valid_period": "2020-01-18 ~ 2022-01-17"
},
{
"cert_number": "20230517020025",
"changes": "기업명, 대표자",
"disclosure_date": "2023-05-17",
"first_cert_date": "2006-10-18",
"no": "8",
"type": "연구개발유형",
"valid_period": "2023-05-17 ~ 2026-05-16"
}
],
"company_name": "베타바이오 주식회사",
"corp_no": "135511-*******",
"financials": {
"2022": {
"capital_stock": 4563569000,
"cost_of_sales": 1429314000,
"current_assets": 1131738000,
"current_liabilities": 2843810000,
"gross_profit": 16151000,
"net_income": -1000891000,
"net_income_bs": -1000891000,
"non_current_assets": 11971959000,
"non_current_liabilities": 2379967000,
"non_operating_expenses": 174426000,
"non_operating_income": 255754000,
"operating_profit": -1082219000,
"revenue": 1445465000,
"sga_expenses": 1098370000,
"total_assets": 13103697000,
"total_equity": 7879920000,
"total_liabilities": 5223777000
},
"2023": {
"capital_stock": 4819608000,
"cost_of_sales": 1620977000,
"current_assets": 1241669000,
"current_liabilities": 353526000,
"gross_profit": 468345000,
"net_income": -1113552000,
"net_income_bs": -1113552000,
"non_current_assets": 11946359000,
"non_current_liabilities": 4950649000,
"non_operating_expenses": 724359000,
"non_operating_income": 234169000,
"operating_profit": -623362000,
"revenue": 2089322000,
"sga_expenses": 1091707000,
"total_assets": 13188028000,
"total_equity": 7883853000,
"total_liabilities": 5304175000
},
"2024": {
"capital_stock": 7155853000,
"cost_of_sales": 3204176000,
"current_assets": 2621257000,
"current_liabilities": 388524000,
"gross_profit": 536117000,
"net_income": -462702000,
"net_income_bs": -462702000,
"non_current_assets": 12153537000,
"non_current_liabilities": 4832148000,
"non_operating_expenses": 573720000,
"non_operating_income": 573715000,
"operating_profit": -462697000,
"revenue": 3740293000,
"sga_expenses": 998814000,
"total_assets": 14774794000,
"total_equity": 9554122000,
"total_liabilities": 5220672000
}
},
"industry": "화장품 제조업",
"investment": [
{
"amount": "999,998,000",
"changes": "999,998,000",
"date": "2019-02-28"
}
],
"main_products": "베타글루칸리얼",
"phone": "031-497-****",
"years": [
2024,
2023,
2022
]
}